BNP Paribas Financial Markets’s GSK GSK Stock Holding History

BNP Paribas Financial Markets’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$68.9M	Sell	1,313,691 -384,607	-23%	-$20.3M	0.02%	609
2026 Q1	$93.7M	Buy	1,698,298 +1,321,421	+351%	+$71.6M	0.05%	436
2025 Q4	$18.5M	Buy	376,877 +330,906	+720%	+$15.4M	0.01%	1232
2025 Q3	$1.98M	Buy	45,971 +34,572	+303%	+$1.35M	﹤0.01%	2619
2025 Q2	$438K	Sell	11,399 -8,630	-43%	-$330K	﹤0.01%	3405
2025 Q1	$776K	Sell	20,029 -347,286	-95%	-$12.7M	﹤0.01%	2946
2024 Q4	$12.4M	Buy	+367,315	New	+$13.2M	0.01%	1240
2022 Q3	–	Sell	-3,218,302	Closed	-$175M	–	4848
2022 Q2	$175M	Buy	3,218,302 +21,472	+0.7%	+$1.19M	0.27%	79
2022 Q1	$174M	Buy	3,196,830 +100,708	+3%	+$5.47M	0.23%	79
2021 Q4	$171M	Sell	3,096,122 -1,707,949	-36%	-$88.8M	0.24%	77
2021 Q3	$229M	Sell	4,804,071 -4,913	-0.1%	-$247K	0.33%	58
2021 Q2	$239M	Buy	4,808,984 +4,798,605	+46,234%	+$231M	0.32%	61
2021 Q1	$463K	Sell	10,379 -27,836	-73%	-$1.26M	﹤0.01%	2605
2020 Q4	$1.76M	Buy	38,215 +30,820	+417%	+$1.42M	﹤0.01%	1683
2020 Q3	$348K	Sell	7,395 -339	-4%	-$17K	﹤0.01%	2430
2020 Q2	$394K	Buy	7,734 +1,872	+32%	+$96K	﹤0.01%	2198
2020 Q1	$278K	Sell	5,862 -24,694	-81%	-$1.32M	﹤0.01%	2685
2019 Q4	$1.79M	Sell	30,556 -37,211	-55%	-$2.07M	﹤0.01%	1730
2019 Q3	$3.62M	Buy	67,767 +10,593	+19%	+$545K	0.01%	1224
2019 Q2	$2.86M	Sell	57,174 -2,943	-5%	-$148K	0.01%	1298
2019 Q1	$3.14M	Buy	60,117 +35,750	+147%	+$1.79M	0.01%	1195
2018 Q4	$1.16M	Sell	24,367 -14,109	-37%	-$695K	﹤0.01%	1535
2018 Q3	$1.93M	Buy	38,476 +2,505	+7%	+$127K	﹤0.01%	1508
2018 Q2	$1.81M	Sell	35,971 -6,943	-16%	-$350K	﹤0.01%	1517
2018 Q1	$2.1M	Sell	42,914 -8,384	-16%	-$390K	﹤0.01%	1368
2017 Q4	$2.27M	Sell	51,298 -30,567	-37%	-$1.41M	﹤0.01%	1416
2017 Q3	$4.15M	Sell	81,865 -3,041	-4%	-$154K	0.01%	857
2017 Q2	$4.58M	Sell	84,906 -6,637	-7%	-$354K	0.01%	806
2017 Q1	$4.82M	Buy	91,543 +14,105	+18%	+$716K	0.01%	780
2016 Q4	$3.73M	Sell	77,438 -47,844	-38%	-$2.36M	0.02%	671
2016 Q3	$6.75M	Buy	125,282 +11,495	+10%	+$630K	0.03%	377
2016 Q2	$6.16M	Buy	113,787 +2,457	+2%	+$129K	0.03%	414
2016 Q1	$5.64M	Buy	111,330 +66,975	+151%	+$3.34M	0.02%	524
2015 Q4	$2.24M	Sell	44,355 -33,248	-43%	-$1.69M	0.01%	661
2015 Q3	$3.73M	Sell	77,603 -66,022	-46%	-$3.44M	0.01%	713
2015 Q2	$7.48M	Buy	143,625 +97,190	+209%	+$5.47M	0.02%	462
2015 Q1	$2.68M	Sell	46,435 -34,670	-43%	-$1.99M	0.01%	787
2014 Q4	$4.33M	Buy	81,105 +379	+0.5%	+$21.2K	0.02%	698
2014 Q3	$4.64M	Buy	80,726 +71,314	+758%	+$4.37M	﹤0.01%	750
2014 Q2	$608K	Sell	9,412 -191	-2%	-$12.9K	﹤0.01%	1410
2014 Q1	$665K	Buy	9,603 +5,345	+126%	+$361K	﹤0.01%	1325
2013 Q4	$284K	Sell	4,258 -414,650	-99%	-$26.9M	﹤0.01%	1430
2013 Q3	$26.3M	Buy	418,908 +413,632	+7,840%	+$26.6M	0.02%	276
2013 Q2	$330K	Buy	+5,276	New	+$335K	﹤0.01%	1917

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BNP Paribas Financial Markets's GSK Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its GSK (GSK) stake by 23% in Q2 2026, selling an estimated $20.3M and leaving 1,313,691 shares worth $68.9M. The position accounts for 0.02% of the portfolio, ranked #609.

BNP Paribas Financial Markets first reported a position in GSK in Q2 2013 and has held it in 44 quarters since. The position peaked at $239M in Q2 2021. 1,039 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

BNP Paribas Financial Markets held 1,313,691 shares of GSK worth $68.9M as of Q2 2026.
BNP Paribas Financial Markets sold 384,607 GSK shares in Q2 2026, an estimated $20.3M.
GSK made up 0.02% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #609 holding.
BNP Paribas Financial Markets first reported a position in GSK in Q2 2013 and has held it in 44 quarters since.
BNP Paribas Financial Markets's GSK position peaked at $239M in Q2 2021.
1,039 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.